Assets in USD of DICE Therapeutics, Inc. from Q4 2020 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: DICE Therapeutics, Inc. quarterly Assets history and change rate from Q4 2020 to Q2 2023.
DICE Therapeutics, Inc. Assets for the quarter ending 30 Jun 2023 was $550,673,000, a 82% increase year-over-year.
Source SEC data: View on sec.gov

Assets, Quarterly (USD)

Assets, YoY Quarterly Change (%)

DICE Therapeutics, Inc. Quarterly Assets (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2023	$550,673,000	+$248,092,000	+82%	30 Jun 2023	10-Q	08 Aug 2023	2023	Q2
Q1 2023	$575,604,000	+$250,995,000	+77%	31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$593,978,000	+$268,224,000	+82%	31 Dec 2022	10-Q	08 Aug 2023	2023	Q2
Q3 2022	$284,994,000	-$57,388,000	-17%	30 Sep 2022	10-Q	09 Nov 2022	2022	Q3
Q2 2022	$302,581,000			30 Jun 2022	10-Q	11 Aug 2022	2022	Q2
Q1 2022	$324,609,000			31 Mar 2022	10-Q	12 May 2022	2022	Q1
Q4 2021	$325,754,000	+$261,893,000	+410%	31 Dec 2021	10-K	15 Mar 2023	2022	FY
Q3 2021	$342,382,000			30 Sep 2021	10-Q	12 Nov 2021	2021	Q3
Q4 2020	$63,861,000			31 Dec 2020	10-K	28 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.